𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Treatment persistence with adalimumab, etanercept, or infliximab in combination with methotrexate and the effects on health care costs in patients with rheumatoid arthritis

✍ Scribed by Boxiong Tang; Mirza Rahman; Heidi C. Waters; Peter Callegari


Book ID
117321849
Publisher
Elsevier Science
Year
2008
Tongue
English
Weight
765 KB
Volume
30
Category
Article
ISSN
0149-2918

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Combination therapy with etanercept and
✍ Mark C. Genovese; Stanley Cohen; Larry Moreland; Deborah Lium; Sean Robbins; Ric πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 109 KB πŸ‘ 2 views

## Abstract ## Objective To determine the potential for additive or synergistic effects of combination therapy with the selective anti–tumor necrosis factor Ξ± agent etanercept and the anti–interleukin‐1 agent anakinra. ## Methods Two hundred forty‐four patients in whom rheumatoid arthritis (RA)